Detailed information for compound 329664

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 405.493 | Formula: C23H27N5O2
  • H donors: 1 H acceptors: 3 LogP: 4.9 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCc1c(OCCCCOc2ccc(cc2)c2n[nH]nn2)ccc2c1ccn2C
  • InChi: 1S/C23H27N5O2/c1-3-6-20-19-13-14-28(2)21(19)11-12-22(20)30-16-5-4-15-29-18-9-7-17(8-10-18)23-24-26-27-25-23/h7-14H,3-6,15-16H2,1-2H3,(H,24,25,26,27)
  • InChiKey: CHVMIGYYFMRIHJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi dihydrofolate reductase-thymidylate synthase 0.1418 0.5232 0.5
Loa Loa (eye worm) hypothetical protein 0.2293 1 1
Toxoplasma gondii bifunctional dihydrofolate reductase-thymidylate synthase 0.1418 0.5232 0.5
Chlamydia trachomatis dihydrofolate reductase 0.2211 0.9552 0.5
Loa Loa (eye worm) dihydrofolate reductase 0.2211 0.9552 0.9552
Plasmodium vivax bifunctional dihydrofolate reductase-thymidylate synthase, putative 0.1418 0.5232 0.5
Treponema pallidum sodium- and chloride- dependent transporter 0.2293 1 0.5
Onchocerca volvulus 0.2293 1 1
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase 0.1418 0.5232 0.5
Loa Loa (eye worm) hypothetical protein 0.2293 1 1
Loa Loa (eye worm) norepinephrine transporter 0.2293 1 1
Schistosoma mansoni sodium/chloride dependent transporter 0.2293 1 1
Schistosoma mansoni norepinephrine/norepinephrine transporter 0.2293 1 1
Mycobacterium tuberculosis Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) 0.2211 0.9552 1
Brugia malayi dihydrofolate reductase family protein 0.2211 0.9552 0.9552
Echinococcus granulosus dihydrofolate reductase 0.2211 0.9552 0.9552
Brugia malayi Dihydrofolate reductase 0.2211 0.9552 0.9552
Mycobacterium leprae DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) 0.2211 0.9552 1
Mycobacterium ulcerans dihydrofolate reductase DfrA 0.2211 0.9552 1
Leishmania major dihydrofolate reductase-thymidylate synthase 0.1418 0.5232 0.5
Loa Loa (eye worm) solute carrier family 6 member 4 0.2293 1 1
Loa Loa (eye worm) hypothetical protein 0.2293 1 1
Schistosoma mansoni dihydrofolate reductase 0.2211 0.9552 0.9552
Trypanosoma brucei dihydrofolate reductase-thymidylate synthase 0.1418 0.5232 0.5
Echinococcus multilocularis serotonin transporter 0.2293 1 1
Echinococcus granulosus serotonin transporter 0.2293 1 1
Loa Loa (eye worm) serotonin transporter b 0.2293 1 1
Echinococcus multilocularis dihydrofolate reductase 0.2211 0.9552 0.9552

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) NA 0 nM Effective concentration for stimulation of [35S]-GTP-gammaS, binding to human metabotropic glutamate receptor 2 incubated at 30 degree C for 1 hr; NA = not active at 10 uM ChEMBL. 16005222

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.